Patent details
92164 Product Name: "Pertuzumab"
Basic Information
- Publication number:
- 92164
- Type:
- SPC
- SPC Type:
- Medical
- Basic Patent Number:
- EP009431156
- Legal Status:
- Active
- Application number:
- 92164
- First applicant's nationality:
- Procedural language:
- French
Marketing Authorization
- Marketing Authorization Number:
- EU/1/13/813/001 - Perjeta -pertuzumab
- Marketing Authorization Type:
- Marketing Authorization Date:
- 04/03/2013
- Marketing Authorization Status:
- Accepted
- Marketing Authorization Country:
Dates
- Filing date:
- 07/03/2013
- First Marketing Authorization date:
- 04/03/2013
- Grant date:
- 07/05/2013
- Activation date:
- 23/06/2020
- Publication date:
- 07/05/2013
- Lapsed date:
- Expiration date:
- Renunciation date:
- Revocation date:
- Annulment date:
- Basic SPC Expiration:
- 23/06/2025
- SPC Extension Expiration:
- 23/06/2025
- Rejection date:
- Withdrawal date:
Owner
- From:
- 07/03/2013
- Name:
- GENENTECH, INC.
- Address:
- 1 DNA WAY, SOUTH SAN FRANCISCO CA 94080-4990, United States (US)
Agent
- Name:
- OFFICE FREYLINGER S.A.
- From:
- 07/03/2013
- Address:
- Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
- To:
Inventor
1
- Name:
- ADAMS Camellia, W.
- Address:
- United States (US)
2
- Name:
- PRESTA Leonard, G.
- Address:
- United States (US)
3
- Name:
- SLIWKOWSKY Mark
- Address:
- United States (US)
Publication
Bulletin
- Bulletin Heading:
- SPC3
- Bulletin edition number:
- 2020/08
- Publication date:
- 13/07/2020
- Description:
- Section E : Supplementary Protection certificates entered into force – IA publication
Annual Fees
- Annual Fee Due Date:
- Annual Fee Number:
- Expected Payer:
- Last Annual Fee Payment Date:
- 20/02/2024
- Last Annual Fee Paid Number:
- 25
- Last Annual Fee Paid Amount:
- 450 Euro
- Payer:
- ANAQUA SERVICES (ANC. SGA2)
| Filing date | Document type | Number of pages |
|---|